Recent Patents on Anti-Cancer Drug Discovery

Papers
(The H4-Index of Recent Patents on Anti-Cancer Drug Discovery is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Acknowledgement to Contributors41
Acknowledgement to Reviewers25
L-Selenomethylselenocysteine Exerts Inhibitory Effects on the Progression of Esophageal Cancer by Targeting the PI3K/AKT Signaling Pathway22
High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer18
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies17
Current Prospects for Adrenocortical Carcinoma Pharmacotherapy17
Research Progress on the Anticancer Activity of Plant Polysaccharides16
Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration16
Patent Selections15
The Prognostic Role of Interferon Gamma-inducible Protein 30 in Clear Cell Renal Cell Carcinoma with Immune Infiltrates15
Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta-Analysis and Systematic Review14
Santacruzamate A Compositions, Analogs and Methods of Use: A Patent Evaluation of WO 2014/018913 (A2)14
Bioinformatic Analysis and Experimental Validation of HMGA2-AS1 as a Prognostic Biomarker Associated with Immune Infiltration in Gastric Cancer14
Nanomaterials for Diagnosis and Treatment of Lung Cancer: A Review of Recent Patents14
Protective Assessment of Novel (BNC Formulation) against Brain Tumor14
0.097487926483154